These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5344 related items for PubMed ID: 6241293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
    Ernstoff MS, Fusi S, Kirkwood JM.
    J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
    [Abstract] [Full Text] [Related]

  • 3. Parameters of interferon action: I. Immunological effects of whole cell leukocyte interferon (IFN-alpha) in phase I-II trials.
    Ernstoff MS, Fusi S, Kirkwood JM.
    J Biol Response Mod; 1983; 2(6):528-39. PubMed ID: 6363630
    [Abstract] [Full Text] [Related]

  • 4. Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population.
    Golub SH, Dorey F, Hara D, Morton DL, Burk MW.
    J Natl Cancer Inst; 1982 May; 68(5):703-10. PubMed ID: 6175787
    [Abstract] [Full Text] [Related]

  • 5. Comparative study on the effects of recombinant alpha-2 interferon on immune function in patients with disseminated melanoma.
    Hersey P, Coates A, Rallings M, Hall C, MacDonald M, Spurling A, Edwards A, McCarthy WH, Milton GW.
    J Biol Response Mod; 1986 Jun; 5(3):236-49. PubMed ID: 3487622
    [Abstract] [Full Text] [Related]

  • 6. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
    Golub SH, D'Amore P, Rainey M.
    J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
    [Abstract] [Full Text] [Related]

  • 7. [Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets].
    Numa Y, Kawamoto K, Matsumura H.
    No Shinkei Geka; 1991 Feb; 19(2):121-8. PubMed ID: 1708857
    [Abstract] [Full Text] [Related]

  • 8. Suppression of human NK cell cytotoxicity by an MLC-Generated cell population.
    D'Amore PJ, Golub SH.
    J Immunol; 1985 Jan; 134(1):272-9. PubMed ID: 3155463
    [Abstract] [Full Text] [Related]

  • 9. [Deficit of natural killer cells (NK cells) in the peripheral blood of patients with atopic dermatitis].
    Reinhold U, Wehrmann W, Bauer R, Kreysel HW.
    Hautarzt; 1986 Aug; 37(8):438-43. PubMed ID: 2944856
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA, Tötterman TH.
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [Abstract] [Full Text] [Related]

  • 11. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
    Gerstein HC, Rastogi B, Iwatani Y, Iitaka M, Row VV, Volpé R.
    Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
    [Abstract] [Full Text] [Related]

  • 12. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
    Brennan PC, Graham MA, Triano JJ, Hondras MA, Anderson RJ.
    J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
    [Abstract] [Full Text] [Related]

  • 13. Intraperitoneal administration of human recombinant interferon-alpha in patients with ovarian cancer: effects on lymphocyte phenotype and cytotoxicity.
    Lichtenstein A, Spina C, Berek JS, Jung T, Zighelboim J.
    Cancer Res; 1988 Oct 15; 48(20):5853-9. PubMed ID: 3167841
    [Abstract] [Full Text] [Related]

  • 14. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.
    Lew F, Tsang P, Solomon S, Selikoff IJ, Bekesi JG.
    J Clin Lab Immunol; 1984 Jul 15; 14(3):115-21. PubMed ID: 6237206
    [Abstract] [Full Text] [Related]

  • 15. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M, Vinzenz K, Kokoschka EM, Kokoschka R.
    Nat Immun Cell Growth Regul; 1985 Jul 15; 4(6):315-27. PubMed ID: 4088287
    [Abstract] [Full Text] [Related]

  • 16. Normal values of peripheral lymphocyte populations and T cell subsets at a fixed time of day: a flow cytometric analysis with monoclonal antibodies in 210 healthy adults.
    Ohta Y, Fujiwara K, Nishi T, Oka H.
    Clin Exp Immunol; 1986 Apr 15; 64(1):146-9. PubMed ID: 2942319
    [Abstract] [Full Text] [Related]

  • 17. A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.
    Velardi A, Grossi CE, Cooper MD.
    J Immunol; 1985 Jan 15; 134(1):58-64. PubMed ID: 3155472
    [Abstract] [Full Text] [Related]

  • 18. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
    Tilden AB, Abo T, Balch CM.
    J Immunol; 1983 Mar 15; 130(3):1171-5. PubMed ID: 6218202
    [Abstract] [Full Text] [Related]

  • 19. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL, Benike CJ, Phillips JH, Engleman EG.
    J Immunol; 1985 Feb 15; 134(2):794-801. PubMed ID: 3871216
    [Abstract] [Full Text] [Related]

  • 20. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
    Yanagihara Y, Tochizawa S, Ishii K, Hirai Y.
    Gan To Kagaku Ryoho; 1986 Feb 15; 13(2):342-8. PubMed ID: 3947110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 268.